LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | PD0325901 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 2470 | 4513 | 0.5473 | 0.3766 |
MDA-MB-231 | PD0325901 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 2428 | 4513 | 0.5379 | 0.3637 |
MDA-MB-231 | PD173074 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4694 | 4513 | 1.0401 | 1.0552 |
MDA-MB-231 | PD184352 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4050 | 4513 | 0.8973 | 0.8586 |
MDA-MB-231 | Pelitinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4532 | 4513 | 1.0041 | 1.0057 |
MDA-MB-231 | PF431396 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3390 | 4513 | 0.7511 | 0.6573 |
MDA-MB-231 | PF477736 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3964 | 4513 | 0.8783 | 0.8324 |
MDA-MB-231 | PF562271 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3386 | 4513 | 0.7503 | 0.6562 |
MDA-MB-231 | PHA-665752 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4659 | 4513 | 1.0324 | 1.0446 |
MDA-MB-231 | PHA-793887 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 1698 | 4513 | 0.3762 | 0.1410 |
MDA-MB-231 | PI103 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 2668 | 4513 | 0.5912 | 0.4370 |
MDA-MB-231 | PLX-4720 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4456 | 4513 | 0.9873 | 0.9825 |
MDA-MB-231 | QL-X-138 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3854 | 4513 | 0.8540 | 0.7990 |
MDA-MB-231 | QL-XII-47 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 2314 | 4513 | 0.5127 | 0.3289 |
MDA-MB-231 | Radicicol | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3425 | 4513 | 0.7588 | 0.6679 |
MDA-MB-231 | Radicicol | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3118 | 4513 | 0.6908 | 0.5742 |
MDA-MB-231 | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4391 | 4513 | 0.9728 | 0.9626 |
MDA-MB-231 | Ruxolitinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4191 | 4513 | 0.9285 | 0.9016 |
MDA-MB-231 | XL147 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4962 | 4513 | 1.0993 | 1.1368 |
MDA-MB-231 | Saracatinib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3260 | 4513 | 0.7224 | 0.6177 |
MDA-MB-231 | Selumetinib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3641 | 4513 | 0.8067 | 0.7338 |
MDA-MB-231 | Sirolimus | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3485 | 4513 | 0.7721 | 0.6862 |
MDA-MB-231 | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4569 | 4513 | 1.0123 | 1.0169 |
MDA-MB-231 | SU11274 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4521 | 4513 | 1.0016 | 1.0022 |
MDA-MB-231 | Fedratinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4035 | 4513 | 0.8940 | 0.8541 |